TY - JOUR AU - Cortes-Vicente, Elena AU - Alvarez-Velasco, Rodrigo AU - Pla-Junca, Francesc AU - Rojas-Garcia, Ricard AU - Paradas, Carmen AU - Sevilla, Teresa AU - Casasnovas, Carlos AU - Gomez-Caravaca, Maria Teresa AU - Pardo, Julio AU - Ramos-Fransi, Alba AU - Pelayo-Negro, Ana Lara AU - Gutierrez-Gutierrez, Gerardo AU - Turon-Sans, Janina AU - Lopez-de-Munain, Adolfo AU - Guerrero-Sola, Antonio AU - Jerico, Ivonne AU - Martin, Maria Asuncion AU - Mendoza, Maria Dolores AU - Moris, German AU - Velez-Gomez, Beatriz AU - Garcia-Sobrino, Tania AU - Pascual-Goñi, Elba AU - Reyes-Leiva, David AU - Illa, Isabel AU - Gallardo, Eduard PY - 2022 DO - 10.1002/acn3.51492 UR - http://hdl.handle.net/10668/19730 T2 - Annals of clinical and translational neurology AB - To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment. This observational retrospective cross-sectional... LA - en PB - John Wiley & Sons Ltd. KW - Cross-Sectional Studies KW - Humans KW - Humans KW - Outcome Assessment, Health Care KW - Spain KW - Middle Aged KW - Adult KW - Aged KW - Female KW - Follow-Up Studies KW - Immunologic Factors KW - Male KW - Myasthenia Gravis KW - Registries KW - Retrospective Studies TI - Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome. TY - research article VL - 9 ER -